Powerful antibody to kill dengue virus found

Image
IANS Singapore
Last Updated : Feb 21 2015 | 11:55 AM IST

Raising hope for the development of effective dengue treatment, researchers have identified a super-potent antibody which requires a minute amount to neutralise the virus.

Only nine-10 g of antibody 5J7 is needed to stop the infection of dengue serotype 3 virus (DENV-3), the findings showed.

"We are optimistic that we will make a treatment breakthrough within these few years but antibodies against all the other serotypes have to be identified first," said senior author Shee Mei Lok from the Duke-NUS Graduate Medical School, Singapore.

Over the last 50 years, the incidence of dengue virus has increased by 30 times worldwide. However, till now, there is no licensed dengue vaccine or therapeutic agent due to the presence of four circulating virus serotypes (DENV1-4) complicating their development, the study noted.

In this recent study, researchers isolated 5J7 from 200 different candidate antibody molecules by studying blood samples from a dengue-infected patient.

By examining the virus-antibody complex structure at very high magnification, they showed that each arm of the antibody is surprisingly effective in grabbing three surface proteins on the surface of the virus at the same time.

"The movement of virus surface proteins is highly essential for invading cells - you can think of antibody 5J7 locking the virus surface proteins, thus strapping the virus," she pointed out.

The study appeared in the journal Nature Communications.

--Ind-Asian News Service

gb/pku/vm

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 21 2015 | 11:54 AM IST

Next Story